SSTR2 and medullary thyroid gland carcinoma: These include cell lines derived from pNETs (i.e. BON-1 and QGP-1), pulmonary NETs (i.e. NCI-H727), siNETs (i.e. GOT-1) and medullary thyroid cancer (i.e. TT and MZ-CRC-1), which are all characterized by their own basal SSTR2 expression levels.